trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Surgical implants exist that improve vision loss caused by glaucoma

the verdict
SUPPORTED
the evidence backs this
Recorded sources
7 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that surgical implants exist that improve vision loss caused by glaucoma?

Yes. Multiple clinical studies and trials demonstrate that surgical implants, such as microstents and drainage devices, effectively lower intraocular pressure and help preserve vision in patients with glaucoma.

Verdict: SUPPORTED · 7 sources for, 0 against · Last checked

The analysis

The retrieved papers provide extensive evidence of various surgical implants (microstents, drainage devices, biodegradable implants) explicitly utilized to manage glaucoma by lowering intraocular pressure and preserving visual function. No papers contradict the premise.

Evidence for · 7
2025
Evaluates the Hydrus microstent and iStent inject for treating primary open-angle glaucoma, demonstrating their use in reducing intraocular pressure.
Get citation
Komzak, K., Allen, P. L., & Toh, T. (2025). Minimally invasive glaucoma surgery: comparison of Hydrus microstent with iStent
                    <i>inject</i>
                    in primary open-angle glaucoma. doi.org. https://doi.org/10.1136/bmjophth-2024-001946

See more details
More for · 6
2026
Discusses glaucoma drainage implants, such as the Paul glaucoma implant, used in managing refractory glaucoma.
Get citation
S, A., A, A., A, A., & M, A. (2026). Panophthalmitis With Orbital Cellulitis Following Glaucoma Drainage Implant Surgery in an Adult Patient.. doi.org. https://doi.org/10.12659/ajcr.951844

2026
Reports long-term clinical outcomes of ciliary sulcus placement of glaucoma drainage devices (GDDs) in reducing intraocular pressure and preserving visual function.
Get citation
Z, A., S, H., H, K., & A, E. (2026). A Simplified Technique for Glaucoma Drainage Device Ciliary Sulcus Implantation.. doi.org. https://doi.org/10.7759/cureus.105123

2026
Examines the use of modified Ahmed ClearPath glaucoma drainage devices combined with cataract surgery to reduce intraocular pressure in patients with advanced glaucoma.
Get citation
D, L., I, C., & I, N. (2026). A novel retrobulbar/intraconal surgical approach with combined cataract extraction and a modified AHMED ClearPath 250mm<sup>2</sup> tube in the ciliary sulcus with an inferior sclerotomy in black and Afro-Latino patients with advanced glaucoma: a 6-month retrospective study.. doi.org. https://doi.org/10.3389/fopht.2026.1738832

2026
Evaluates the intraocular pressure-lowering and antifibrotic efficacy of a biodegradable glaucoma drainage implant in an animal model.
Get citation
W, L., Q, G., L, L., H, L., Y, C., M, X., F, C., Y, W., X, L., & L, X. (2026). Long-Term Intraocular Pressure-Lowering and Antifibrotic Effects of a Biodegradable HA-Mg Glaucoma Drainage Implant in a Chronic Glaucoma Rabbit Model.. doi.org. https://doi.org/10.1167/tvst.15.4.16

2026
Demonstrates the long-term efficacy of combined Hydrus microstent and cataract surgery in lowering intraocular pressure across different types of glaucoma.
Get citation
KC, N., E, N., S, C., S, R., N, N., AG, I., & S, L. (2026). Long-term efficacy of combined phacoemulsification and Hydrus microstent in open-angle glaucoma versus combined-mechanism/primary angle closure glaucoma: a retrospective cohort study.. doi.org. https://doi.org/10.1186/s12886-026-04875-w

2026
Introduces minimally invasive glaucoma surgery microstents designed to facilitate aqueous humor drainage and lower intraocular pressure.
Get citation
Y, Z., Y, Y., C, C., L, M., J, C., & Z, Y. (2026). Enabling adaptability and hydraulic resistance in minimally invasive glaucoma surgery using an architecture-driven approach.. doi.org. https://doi.org/10.1016/j.isci.2026.115614

What does the evidence say?

The retrieved papers provide extensive evidence of various surgical implants (microstents, drainage devices, biodegradable implants) explicitly utilized to manage glaucoma by lowering intraocular pressure and preserving visual function. No papers contradict the premise.

Receipt History
first checked04 Aug 2026
judged → SUPPORTED · 7904 Aug 2026
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work